Related Articles |
Respiratory Syncytial Virus Infection: An Illness for All Ages.
Clin Chest Med. 2017 Mar;38(1):29-36
Authors: Walsh EE
Abstract
Respiratory syncytial virus (RSV) is the single most important cause of severe respiratory infection in very young infants. It has also been recently recognized as a significant cause of severe illness in elderly adults, those with underlying cardiopulmonary disease, and the immunocompromised. RSV is suspected of playing a major role in the development of asthma. Prophylaxis in high-risk infants using a monoclonal antibody is the only effective specific therapy available but recent breakthroughs in vaccine design and antiviral drugs offer the promise of effective prophylactic and therapeutic agents against RSV.
PMID: 28159159 [PubMed - in process]